One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry
Author
Abstract
Suggested Citation
Download full text from publisher
To our knowledge, this item is not available for download. To find whether it is available, there are three options:1. Check below whether another version of this item is available online.
2. Check on the provider's web page whether it is in fact available.
3. Perform a search for a similarly titled item that would be available.
Other versions of this item:
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2019. "One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry," Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960435, HAL.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2017. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," MPRA Paper 76903, University Library of Munich, Germany.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960426, HAL.
References listed on IDEAS
- Rebecca Henderson & Iain Cockburn, 1996.
"Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery,"
RAND Journal of Economics, The RAND Corporation, vol. 27(1), pages 32-59, Spring.
- Rebecca Henderson & Iain Cockburn, "undated". "Scale, Scope and Spillovers: The Determinants of Research Productivity in Drug Discovery," Working Papers ec25/94, Department of Economics, University of Lancaster.
- d'Aspremont, Claude & Jacquemin, Alexis, 1988.
"Cooperative and Noncooperative R&D in Duopoly with Spillovers,"
American Economic Review, American Economic Association, vol. 78(5), pages 1133-1137, December.
- d'ASPREMONT, Claude & JACQUEMIN, Alexis, 1988. "Cooperative and noncooperative R&D in duopoly with spillovers," LIDAM Reprints CORE 823, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Versaevel Bruno & Vencatachellum Désiré, 2009.
"R&D Delegation in a Duopoly with Spillovers,"
The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 9(1), pages 1-42, December.
- Désiré Vencatachellum & Bruno Versaevel, 2005. "R&D Delegation in a Duopoly with Spillovers," Cahiers de recherche 05-01, HEC Montréal, Institut d'économie appliquée.
- Désiré Vencatachellum & Bruno Versaevel, 2006. "R&D Delegation in a Duopoly with Spillovers," Post-Print halshs-00142520, HAL.
- Bruno Versaevel & Désiré Vencatachellum, 2006. "R&D Delegation in a Duopoly with Spillovers," Working Papers 0610, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
- Leten, Bart & Kelchtermans, Stijn & Belderbos, Ren, 2010. "Internal Basic Research, External Basic Research and the Technological Performance of Pharmaceutical Firms," Working Papers 2010/12, Hogeschool-Universiteit Brussel, Faculteit Economie en Management.
- Galambos, Louis & Sturchio, Jeffrey L., 1998. "Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation," Business History Review, Cambridge University Press, vol. 72(2), pages 250-278, July.
- Comanor, William S. & Scherer, F.M., 2013. "Mergers and innovation in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 32(1), pages 106-113.
- Daniel F. Spulber, 2013. "How Do Competitive Pressures Affect Incentives to Innovate When There Is a Market for Inventions?," Journal of Political Economy, University of Chicago Press, vol. 121(6), pages 1007-1054.
- Ashish Arora & Alfonso Gambardella, 2010. "Ideas for rent: an overview of markets for technology," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 19(3), pages 775-803, June.
- Anton, James J & Yao, Dennis A, 1994. "Expropriation and Inventions: Appropriable Rents in the Absence of Property Rights," American Economic Review, American Economic Association, vol. 84(1), pages 190-209, March.
- DiMasi, Joseph A. & Grabowski, Henry G. & Hansen, Ronald W., 2016. "Innovation in the pharmaceutical industry: New estimates of R&D costs," Journal of Health Economics, Elsevier, vol. 47(C), pages 20-33.
- Fabio Pammolli & Massimo Riccaboni & Laura Magazzini, 2010. "The productivity crisis in pharmaceutical R&D," Working Papers 06/2010, University of Verona, Department of Economics.
- Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016.
"Competition and the Efficiency of Markets for Technology,"
Management Science, INFORMS, vol. 62(4), pages 1000-1019, April.
- Allain, Marie-Laure & Henry, Emeric & Kyle, Margaret, 2013. "Competition and the Efficiency of Markets for Technology," TSE Working Papers 13-416, Toulouse School of Economics (TSE).
- Allain, Marie-Laure & Henry, Emeric & Kyle, Margaret, 2013. "Competition and the Efficiency of Markets for Technology," IDEI Working Papers 784, Institut d'Économie Industrielle (IDEI), Toulouse.
- Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016. "Competition and the Efficiency of Markets for Technology," SciencePo Working papers Main hal-03542108, HAL.
- Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016. "Competition and the Efficiency of Markets for Technology," Post-Print hal-03542108, HAL.
- Marco Ceccagnoli & Matthew J. Higgins & Vincenzo Palermo, 2014.
"Behind the Scenes: Sources of Complementarity in R&D,"
Journal of Economics & Management Strategy, Wiley Blackwell, vol. 23(1), pages 125-148, March.
- Marco Ceccagnoli & Matthew J. Higgins & Vincenzo Palermo, 2013. "Behind the Scenes: Sources of Complementarity in R&D," NBER Working Papers 18795, National Bureau of Economic Research, Inc.
- Veugelers, Reinhilde & Cassiman, Bruno, 1999. "Make and buy in innovation strategies: evidence from Belgian manufacturing firms," Research Policy, Elsevier, vol. 28(1), pages 63-80, January.
- Veugelers, Reinhilde & Cassiman, Bruno, 2005.
"R&D cooperation between firms and universities. Some empirical evidence from Belgian manufacturing,"
International Journal of Industrial Organization, Elsevier, vol. 23(5-6), pages 355-379, June.
- Veugelers, Reinhilde & Cassiman, Bruno, 2003. "R&D Cooperation Between Firms and Universities: Some Empirical Evidence from Belgian Manufacturing," CEPR Discussion Papers 3951, C.E.P.R. Discussion Papers.
- Nicholas Bloom & Mark Schankerman & John Van Reenen, 2013.
"Identifying Technology Spillovers and Product Market Rivalry,"
Econometrica, Econometric Society, vol. 81(4), pages 1347-1393, July.
- Nick Bloom & Mark Schankerman & John Van Reenen, 2005. "Identifying technology spillovers and product market rivalry," Proceedings, Federal Reserve Bank of San Francisco.
- Nick Bloom & Mark Schankerman & John Van Reenen, 2005. "Identifying technology spillovers and product market rivalry," STICERD - Economics of Industry Papers 40, Suntory and Toyota International Centres for Economics and Related Disciplines, LSE.
- Bloom, Nick & Schankerman, Mark & Van Reenen, John, 2005. "Identifying technology spillovers and product market rivalry," LSE Research Online Documents on Economics 3728, London School of Economics and Political Science, LSE Library.
- Nicholas Bloom & Mark Schankerman & John Van Reenen, 2005. "Identifying Technology Spillovers and Product Market Rivalry," CEP Discussion Papers dp0675, Centre for Economic Performance, LSE.
- Bloom, Nick & Schankerman, Mark & Van Reenen, John, 2007. "Identifying technology spillovers and product market rivalry," LSE Research Online Documents on Economics 5091, London School of Economics and Political Science, LSE Library.
- Bloom, Nick & Schankerman, Mark & Van Reenen, John, 2013. "Identifying technology spillovers and product market rivalry," LSE Research Online Documents on Economics 46852, London School of Economics and Political Science, LSE Library.
- Bloom, Nick & Schankerman, Mark & Van Reenen, John, 2005. "Identifying technology spillovers and product market rivalry," LSE Research Online Documents on Economics 780, London School of Economics and Political Science, LSE Library.
- Bloom, Nick & Schankerman, Mark & Van Reenen, John, 2005. "Identifying technology spillovers and product market rivalry," LSE Research Online Documents on Economics 5077, London School of Economics and Political Science, LSE Library.
- Schankerman, Mark & Van Reenen, John & Bloom, Nicholas, 2005. "Identifying Technology Spillovers and Product Market Rivalry," CEPR Discussion Papers 4912, C.E.P.R. Discussion Papers.
- Nicholas Bloom & Mark Schankerman & John Van Reenen, 2007. "Identifying Technology Spillovers and Product Market Rivalry," NBER Working Papers 13060, National Bureau of Economic Research, Inc.
- Hagedoorn, John & Wang, Ning, 2012. "Is there complementarity or substitutability between internal and external R&D strategies?," Research Policy, Elsevier, vol. 41(6), pages 1072-1083.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2019.
"One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry,"
Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2017. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," MPRA Paper 76903, University Library of Munich, Germany.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960435, HAL.
- Etienne Billette de Villemeur & Bruno Versaevel, 2019. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," Post-Print hal-02107357, HAL.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960426, HAL.
- Laussel, Didier & Le Breton, Michel, 2001.
"Conflict and Cooperation: The Structure of Equilibrium Payoffs in Common Agency,"
Journal of Economic Theory, Elsevier, vol. 100(1), pages 93-128, September.
- LAUSSEL, Didier & LE BRETON, Michel, 2001. "Conflict and cooperation. The structure of equilibrium payoffs in common agency," LIDAM Reprints CORE 1519, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- repec:bla:jindec:v:46:y:1998:i:2:p:125-56 is not listed on IDEAS
- Danzon, Patricia M. & Nicholson, Sean & Pereira, Nuno Sousa, 2005.
"Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances,"
Journal of Health Economics, Elsevier, vol. 24(2), pages 317-339, March.
- Patricia M. Danzon & Sean Nicholson & Nuno Sousa Pereira, 2003. "Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances," NBER Working Papers 9615, National Bureau of Economic Research, Inc.
- Henderson, Rebecca., 1994. "The evolution of integrative capability : innovation in cardiovascular drug discovery," Working papers 3711-94., Massachusetts Institute of Technology (MIT), Sloan School of Management.
- Philippe Aghion & Jean Tirole, 1994.
"The Management of Innovation,"
The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 109(4), pages 1185-1209.
- Aghion, P. & Tirole, J., 1993. "On the Management of Innovation," Working papers 93-12, Massachusetts Institute of Technology (MIT), Department of Economics.
- Aghion, Philippe & Tirole, Jean, 1994. "On the Management of Innovation," IDEI Working Papers 36, Institut d'Économie Industrielle (IDEI), Toulouse.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G. & Lasagna, Louis, 1991. "Cost of innovation in the pharmaceutical industry," Journal of Health Economics, Elsevier, vol. 10(2), pages 107-142, July.
- B. Douglas Bernheim & Michael D. Whinston, 1986. "Menu Auctions, Resource Allocation, and Economic Influence," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 101(1), pages 1-31.
- Scherer, F.M., 2010. "Pharmaceutical Innovation," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 539-574, Elsevier.
- Jorge Mestre-Ferrandiz;Jon Sussex;Adrian Towse, 2012. "The R&D Cost of a New Medicine," Monograph 000135, Office of Health Economics.
- Martimort David & Stole Lars, 2003.
"Contractual Externalities and Common Agency Equilibria,"
The B.E. Journal of Theoretical Economics, De Gruyter, vol. 3(1), pages 1-40, July.
- Martimort, David & Stole, Lars, 1999. "Contractual Externalities and Common Agency Equilibria," IDEI Working Papers 110, Institut d'Économie Industrielle (IDEI), Toulouse, revised 2003.
- David Martimort & Lars Stole, 2001. "Contractual Externalities and Common Agency Equilibria," CESifo Working Paper Series 581, CESifo.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2003.
"From private to public common agency,"
Journal of Economic Theory, Elsevier, vol. 111(2), pages 305-309, August.
- Etienne Billette de Villemeur & Bruno Versaevel, 2002. "From Private to Public Common Agency," Cahiers de recherche 02-06, HEC Montréal, Institut d'économie appliquée.
- Etienne Billette de Villemeur & Bruno Versaevel, 2003. "From private to public common agency," Post-Print hal-02311683, HAL.
- Bruno Versaevel & Etienne Billette de Villemeur, 2003. "From Private to Public Common Agency," Post-Print halshs-00161728, HAL.
- Josh Lerner & Robert P. Merges, 1998. "The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry," Journal of Industrial Economics, Wiley Blackwell, vol. 46(2), pages 125-156, June.
- Scherer, Frederic Michael, 2011. "R&D Costs and Productivity in Biopharmaceuticals," Scholarly Articles 5688848, Harvard Kennedy School of Government.
- Henriques, Irene, 1990. "Cooperative and Noncooperative R&D in Duopoly with Spillovers: Comment," American Economic Review, American Economic Association, vol. 80(3), pages 638-640, June.
- Bronwyn H. Hall & Nathan Rosenberg (ed.), 2010. "Handbook of the Economics of Innovation," Handbook of the Economics of Innovation, Elsevier, edition 1, volume 1, number 1.
- Wesley M. Cohen & Richard R. Nelson & John P. Walsh, 2000.
"Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not),"
NBER Working Papers
7552, National Bureau of Economic Research, Inc.
- Wesley M Cohen & Richard R Nelson & John P Walsh, 2003. "Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (Or Not)," Levine's Working Paper Archive 618897000000000624, David K. Levine.
- Pennings, Enrico & Sereno, Luigi, 2011. "Evaluating pharmaceutical R&D under technical and economic uncertainty," European Journal of Operational Research, Elsevier, vol. 212(2), pages 374-385, July.
- Josh Lerner & Ulrike Malmendier, 2010.
"Contractibility and the Design of Research Agreements,"
American Economic Review, American Economic Association, vol. 100(1), pages 214-246, March.
- Josh Lerner & Ulrike Malmendier, 2005. "Contractibility and the Design of Research Agreements," NBER Working Papers 11292, National Bureau of Economic Research, Inc.
- Lerner, Josh & Malmendier, Ulrike, 2008. "Contractibility and the Design of Research Agreements," Department of Economics, Working Paper Series qt2gg4h8z0, Department of Economics, Institute for Business and Economic Research, UC Berkeley.
- Jacques Cremer & Michael H. Riordan, 1987. "On Governing Multilateral Transactions with Bilateral Contracts," RAND Journal of Economics, The RAND Corporation, vol. 18(3), pages 436-451, Autumn.
- D. Jane Bower & Erica Whittaker, 1993. "Global R&D networks," Industry and Innovation, Taylor & Francis Journals, vol. 1(1), pages 50-64.
- Gary P. Pisano, 2010. "The evolution of science-based business: innovating how we innovate," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 19(2), pages 465-482, April.
- Pierre Azoulay, 2004. "Capturing Knowledge within and across Firm Boundaries: Evidence from Clinical Development," American Economic Review, American Economic Association, vol. 94(5), pages 1591-1612, December.
- Boris Lokshin & René Belderbos & Martin Carree, 2008.
"The Productivity Effects of Internal and External R&D: Evidence from a Dynamic Panel Data Model,"
Oxford Bulletin of Economics and Statistics, Department of Economics, University of Oxford, vol. 70(3), pages 399-413, June.
- Lokshin, Boris & Belderbos, René & Carree, Martin, 2007. "The Productivity Effects of Internal and External R&D: Evidence From a Dynamic Panel Data Model," MERIT Working Papers 2007-026, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
- Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2007.
"Mergers and acquisitions in the pharmaceutical and biotech industries,"
Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 307-328.
- Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2004. "Mergers and Acquisitions in the Pharmaceutical and Biotech Industries," NBER Working Papers 10536, National Bureau of Economic Research, Inc.
- Arora, Ashish & Gambardella, Alfonso, 1994. "The changing technology of technological change: general and abstract knowledge and the division of innovative labour," Research Policy, Elsevier, vol. 23(5), pages 523-532, September.
- Sudipto Bhattacharya & Sergei Guriev, 2006.
"Patents vs. Trade Secrets: Knowledge Licensing and Spillover,"
Journal of the European Economic Association, MIT Press, vol. 4(6), pages 1112-1147, December.
- Sudipto Bhattacharya & Sergei Guriev, 2004. "Patents vs Trade Secrets: Knowledge Licensing and Spillover," Working Papers w0064, Center for Economic and Financial Research (CEFIR), revised Feb 2006.
- Sudipto Bhattacharya & Sergei Guriev, 2006. "Patents VS Trade Secrets: Knowledge Licensing and Spillover," Post-Print hal-03595505, HAL.
- Sudipto Bhattacharya & Sergei Guriev, 2006. "Patents VS Trade Secrets: Knowledge Licensing and Spillover," SciencePo Working papers Main hal-03595505, HAL.
- Sudipto Bhattacharya & Sergei Guriev, 2004. "Patents vs Trade Secrets: Knowledge Licensing and Spillover," Working Papers w0064, New Economic School (NES), revised Feb 2006.
- Bhattacharya, Sudipto & Guriev, Sergei, 2005. "Patents vs trade secrets: knowledge licensing and spillover," LSE Research Online Documents on Economics 444, London School of Economics and Political Science, LSE Library.
- Arora, Ashish & Fosfuri, Andrea & Gambardella, Alfonso, 2001. "Markets for Technology and Their Implications for Corporate Strategy," Industrial and Corporate Change, Oxford University Press and the Associazione ICC, vol. 10(2), pages 419-451, June.
- Amir, Rabah & Evstigneev, Igor & Wooders, John, 2003.
"Noncooperative versus cooperative R&D with endogenous spillover rates,"
Games and Economic Behavior, Elsevier, vol. 42(2), pages 183-207, February.
- AMIR, Rabah & EVSTIGNEEV, Igor & WOODERS, John, 2001. "Noncooperative versus cooperative R&D with endogenous spillover rates," LIDAM Discussion Papers CORE 2001050, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- AMIR, Rabah & EVSTIGNEEV, Igor & WOODERS, John, 2003. "Noncooperative versus cooperative R&D with endogenous spillover rates," LIDAM Reprints CORE 1650, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- David Martimort, 1996.
"Exclusive Dealing, Common Agency, and Multiprincipals Incentive Theory,"
RAND Journal of Economics, The RAND Corporation, vol. 27(1), pages 1-19, Spring.
- Martimort, D., 1992. "Exclusive Dealing, Common Agency and Multiprincipals Incentive Thoery," Papers 92.278, Toulouse - GREMAQ.
- Martimort, David, 1994. "Exclusive Dealing, Common Agency and Multiprincipals Incentive Theory," IDEI Working Papers 43, Institut d'Économie Industrielle (IDEI), Toulouse, revised 1996.
- Joseph Golec & John Vernon, 2009. "Financial risk of the Biotech Industry versus the Pharmaceutical Industry," Applied Health Economics and Health Policy, Springer, vol. 7(3), pages 155-165, September.
- Higgins, Matthew J., 2007. "The allocation of control rights in pharmaceutical alliances," Journal of Corporate Finance, Elsevier, vol. 13(1), pages 58-75, March.
- John Hagedoorn & Geerte Hesen, 2007. "Contract Law and the Governance of Inter‐Firm Technology Partnerships – An Analysis of Different Modes of Partnering and Their Contractual Implications," Journal of Management Studies, Wiley Blackwell, vol. 44(3), pages 342-366, May.
- Symeonidis, George, 2003. "Comparing Cournot and Bertrand equilibria in a differentiated duopoly with product R&D," International Journal of Industrial Organization, Elsevier, vol. 21(1), pages 39-55, January.
- Vonortas, Nicholas S., 1994. "Inter-firm cooperation with imperfectly appropriable research," International Journal of Industrial Organization, Elsevier, vol. 12(3), pages 413-435, September.
- Versaevel Bruno & Vencatachellum Désiré, 2009.
"R&D Delegation in a Duopoly with Spillovers,"
The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 9(1), pages 1-42, December.
- Désiré Vencatachellum & Bruno Versaevel, 2009. "R&D Delegation in a Duopoly with Spillovers," Post-Print halshs-00956711, HAL.
- Bruno Versaevel & Désiré Vencatachellum, 2009. "R&D Delegation in a Duopoly with Spillovers," Post-Print hal-02312541, HAL.
- Veugelers, Reinhilde, 1997. "Internal R & D expenditures and external technology sourcing," Research Policy, Elsevier, vol. 26(3), pages 303-315, October.
- Edwin Lai & Raymond Riezman & Ping Wang, 2009. "Outsourcing of innovation," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 38(3), pages 485-515, March.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2003.
"From private to public common agency,"
Journal of Economic Theory,
Elsevier, vol. 111(2), pages 305-309, August.
- Etienne Billette de Villemeur & Bruno Versaevel, 2002. "From Private to Public Common Agency," Cahiers de recherche 02-06, HEC Montréal, Institut d'économie appliquée.
- Etienne Billette de Villemeur & Bruno Versaevel, 2003. "From private to public common agency," Post-Print hal-01892869, HAL.
- Etienne Billette de Villemeur & Bruno Versaevel, 2003. "From private to public common agency," Post-Print hal-02311683, HAL.
- Bruno Versaevel & Etienne Billette de Villemeur, 2003. "From Private to Public Common Agency," Post-Print halshs-00161728, HAL.
- Motta, Massimo, 1992.
"Cooperative R&D and vertical product differentiation,"
International Journal of Industrial Organization, Elsevier, vol. 10(4), pages 643-661, December.
- Motta, M., 1991. "Cooperative R&D and vertical product differentiation," LIDAM Discussion Papers CORE 1991028, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
- Scherer, F. M., 2011. "R&D Costs and Productivity in Biopharmaceuticals," Working Paper Series rwp11-046, Harvard University, John F. Kennedy School of Government.
- Pisano, Gary P., 1991. "The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry," Research Policy, Elsevier, vol. 20(3), pages 237-249, June.
- Mowery, David C., 1983. "The relationship between intrafirm and contractual forms of industrial research in American manufacturing, 1900-1940," Explorations in Economic History, Elsevier, vol. 20(4), pages 351-374, October.
- Bruno Cassiman & Reinhilde Veugelers, 2006. "In Search of Complementarity in Innovation Strategy: Internal R& D and External Knowledge Acquisition," Management Science, INFORMS, vol. 52(1), pages 68-82, January.
- repec:hal:spmain:info:hdl:2441/3jesolrqda8pl9qj4osla4hevt is not listed on IDEAS
- Higgins, Matthew J. & Rodriguez, Daniel, 2006. "The outsourcing of R&D through acquisitions in the pharmaceutical industry," Journal of Financial Economics, Elsevier, vol. 80(2), pages 351-383, May.
- Bernheim, B. Douglas & Peleg, Bezalel & Whinston, Michael D., 1987. "Coalition-Proof Nash Equilibria I. Concepts," Journal of Economic Theory, Elsevier, vol. 42(1), pages 1-12, June.
- Sudipto Bhattacharya & Sergei Guriev, 2013.
"Control Rights Over Intellectual Property,"
Journal of Industrial Economics, Wiley Blackwell, vol. 61(3), pages 564-591, September.
- Sudipto Bhattacharya & Sergei Guriev, 2013. "Control Rights over intellectual property," Post-Print hal-03595532, HAL.
- Sudipto Bhattacharya & Sergei Guriev, 2013. "Control Rights over intellectual property," SciencePo Working papers Main hal-03595532, HAL.
- Pisano, Gary P, 1989. "Using Equity Participation to Support Exchange: Evidence from the Biotechnology Industry," The Journal of Law, Economics, and Organization, Oxford University Press, vol. 5(1), pages 109-126, Spring.
- Argyres, Nicholas S. & Liebeskind, Julia Porter, 2002. "Governance inseparability and the evolution of US biotechnology industry," Journal of Economic Behavior & Organization, Elsevier, vol. 47(2), pages 197-219, February.
- Arora, Ashish & Gambardella, Alfonso, 1990. "Complementarity and External Linkages: The Strategies of the Large Firms in Biotechnology," Journal of Industrial Economics, Wiley Blackwell, vol. 38(4), pages 361-379, June.
- Frank T. Rothaermel, 2001. "Incumbent's advantage through exploiting complementary assets via interfirm cooperation," Strategic Management Journal, Wiley Blackwell, vol. 22(6‐7), pages 687-699, June.
- David T. Robinson & Toby E. Stuart, 2007. "Financial Contracting in Biotech Strategic Alliances," Journal of Law and Economics, University of Chicago Press, vol. 50(3), pages 559-596.
- Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016.
"Competition and the Efficiency of Markets for Technology,"
Management Science, INFORMS, vol. 62(4), pages 1000-1019, April.
- Allain, Marie-Laure & Henry, Emeric & Kyle, Margaret, 2013. "Competition and the Efficiency of Markets for Technology," IDEI Working Papers 784, Institut d'Économie Industrielle (IDEI), Toulouse.
- Margaret Kyle & Marie-Laure Allain & Emeric Henry, 2015. "Competition and the Efficiency of Markets for Technology," Post-Print hal-01523017, HAL.
- Allain, Marie-Laure & Henry, Emeric & Kyle, Margaret, 2013. "Competition and the Efficiency of Markets for Technology," TSE Working Papers 13-416, Toulouse School of Economics (TSE).
- Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016. "Competition and the Efficiency of Markets for Technology," Post-Print hal-01952696, HAL.
- Marie-Laure Allain & Emeric Henry & Margaret Kyle, 2016. "Competition and the Efficiency of Markets for Technology," Post-Print hal-03542108, HAL.
- DiMasi, Joseph A. & Hansen, Ronald W. & Grabowski, Henry G., 2003. "The price of innovation: new estimates of drug development costs," Journal of Health Economics, Elsevier, vol. 22(2), pages 151-185, March.
- Cockburn, Iain M. & Henderson, Rebecca M., 2001. "Scale and scope in drug development: unpacking the advantages of size in pharmaceutical research," Journal of Health Economics, Elsevier, vol. 20(6), pages 1033-1057, November.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Francesca Barigozzi & Izabela Jelovac, 2020.
"Research funding and price negotiation for new drugs,"
Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 83-96, October.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02409758, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02409768, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02148454, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02148462, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2020. "Research funding and price negotiation for new drugs," Post-Print halshs-02910863, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Working Papers 1901, Groupe d'Analyse et de Théorie Economique Lyon St-Étienne (GATE Lyon St-Étienne), Université de Lyon.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Working Papers halshs-01987643, HAL.
- Francesca Barigozzi & Izabela Jelovac, 2019. "Research funding and price negotiation for new drugs," Post-Print halshs-02409743, HAL.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2019.
"One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry,"
Journal of Health Economics, Elsevier, vol. 65(C), pages 260-283.
- Billette de Villemeur, Etienne & Versaevel, Bruno, 2017. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," MPRA Paper 76903, University Library of Munich, Germany.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960426, HAL.
- Etienne Billette de Villemeur & Bruno Versaevel, 2019. "One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry," Post-Print hal-02107357, HAL.
- Bruno Versaevel, 2018. "One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry," Post-Print halshs-01960435, HAL.
- Cisnetto, Valentina & Barlow, James, 2020. "The development of complex and controversial innovations. Genetically modified mosquitoes for malaria eradication," Research Policy, Elsevier, vol. 49(3).
- Howell, Sabrina T. & Rathje, Jason & Van Reenen, John & Wong, Jun, 2021.
"Opening up Military Innovation: Causal Effects of 'Bottom-up' Reforms to U.S. Defense Research,"
IZA Discussion Papers
14297, Institute of Labor Economics (IZA).
- Sabrina T. Howell & Jason Rathje & John Van Reenen & Jun Wong, 2021. "Opening up military innovation: causal effects of 'bottom-up' reforms to U.S. defense research," CEP Discussion Papers dp1760, Centre for Economic Performance, LSE.
- Joan Costa‐Font & Rosella Levaggi, 2020. "Innovation, aging, and health care: Unraveling “silver” from “red” herrings?," Health Economics, John Wiley & Sons, Ltd., vol. 29(S1), pages 3-7, October.
- Howell, Sabrina T. & Rathje, Jason & Van Reenen, John & Wong, Jun, 2021.
"Opening up military innovation: causal effects of reforms to US defense research,"
LSE Research Online Documents on Economics
114430, London School of Economics and Political Science, LSE Library.
- Sabrina T. Howell & Jason Rathje & John Van Reenen & Jun Wong, 2021. "Opening up military innovation: causal effects of reforms to U.S. defense research," POID Working Papers 004, Centre for Economic Performance, LSE.
- Billette de Villemeur, Etienne & Scannell, Jack & Versaevel, Bruno, 2021.
"Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?,"
MPRA Paper
108233, University Library of Munich, Germany.
- Jack Scannell & Bruno Versaevel & Etienne Billette de Villemeur, 2022. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," Post-Print hal-03967759, HAL.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Manuel Hermosilla, 2021. "Rushed Innovation: Evidence from Drug Licensing," Management Science, INFORMS, vol. 67(1), pages 257-278, January.
- Versaevel, Bruno & de Villemeur, Étienne, 2003. "Conflict and Cooperation on R&D Markets," IDEI Working Papers 191, Institut d'Économie Industrielle (IDEI), Toulouse.
- Bruce Rasmussen, 2010. "Innovation and Commercialisation in the Biopharmaceutical Industry," Books, Edward Elgar Publishing, number 13680.
- Reuer, Jeffrey & Devarakonda, S.V., 2015. "Mechanisms of hybrid governance : Administrative committees in non-equity alliances," Other publications TiSEM 063d9ccc-59c8-4e76-a77d-8, Tilburg University, School of Economics and Management.
- Tannista Banerjee & Ralph Siebert, 2013.
"The Impact of R&D Cooperation on Drug Variety Offered on the Market: Evidence from the Pharmaceutical Industry,"
Auburn Economics Working Paper Series
auwp2013-20, Department of Economics, Auburn University.
- Tannista Banerjee & Ralph Siebert, 2014. "The Impact of R&D Cooperations on Drug Variety Offered on the Market. Evidence from the Pharmaceutical Industry," CESifo Working Paper Series 4567, CESifo.
- Arora, Ashish & Cohen, Wesley M. & Walsh, John P., 2016.
"The acquisition and commercialization of invention in American manufacturing: Incidence and impact,"
Research Policy, Elsevier, vol. 45(6), pages 1113-1128.
- Ashish Arora & Wesley M. Cohen & John P. Walsh, 2014. "The Acquisition and Commercialization of Invention in American Manufacturing: Incidence and Impact," NBER Working Papers 20264, National Bureau of Economic Research, Inc.
- Kloyer, Martin & Scholderer, Joachim, 2012. "Effective incomplete contracts and milestones in market-distant R&D collaboration," Research Policy, Elsevier, vol. 41(2), pages 346-357.
- Ralph Siebert & Zhili Tian, 2020. "Dynamic Mergers Effects on R&D Investments and Drug Development across Research Phases in the Pharmaceutical Industry," CESifo Working Paper Series 8303, CESifo.
- Hermosilla, Manuel & Wu, Yufei, 2018. "Market size and innovation: The intermediary role of technology licensing," Research Policy, Elsevier, vol. 47(5), pages 980-991.
- Billette de Villemeur, Etienne & Scannell, Jack & Versaevel, Bruno, 2021.
"Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?,"
MPRA Paper
108233, University Library of Munich, Germany.
- Jack Scannell & Bruno Versaevel & Etienne Billette de Villemeur, 2022. "Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain?," Post-Print hal-03967759, HAL.
- Banerjee, Tannista & Siebert, Ralph, 2017. "Dynamic impact of uncertainty on R&D cooperation formation and research performance: Evidence from the bio-pharmaceutical industry," Research Policy, Elsevier, vol. 46(7), pages 1255-1271.
- Ute Laermann-Nguyen & Martin Backfisch, 2021. "Innovation crisis in the pharmaceutical industry? A survey," SN Business & Economics, Springer, vol. 1(12), pages 1-37, December.
- Arora, Ashish & Gambardella, Alfonso, 2010. "The Market for Technology," Handbook of the Economics of Innovation, in: Bronwyn H. Hall & Nathan Rosenberg (ed.), Handbook of the Economics of Innovation, edition 1, volume 1, chapter 0, pages 641-678, Elsevier.
- Nishimura, Junichi & Okada, Yosuke, 2014. "R&D portfolios and pharmaceutical licensing," Research Policy, Elsevier, vol. 43(7), pages 1250-1263.
- Figueroa, Nicolás & Serrano, Carlos J., 2019.
"Patent trading flows of small and large firms,"
Research Policy, Elsevier, vol. 48(7), pages 1601-1616.
- Nicolas Figueroa & Carlos J. Serrano, 2013. "Patent Trading Flows of Small and Large Firms," NBER Working Papers 18982, National Bureau of Economic Research, Inc.
- Martin Backfisch, 2018. "The Development of Firm Size and Innovativeness in the Pharmaceutical industry between 1989 and 2010," MAGKS Papers on Economics 201813, Philipps-Universität Marburg, Faculty of Business Administration and Economics, Department of Economics (Volkswirtschaftliche Abteilung).
- Ashish Arora & Sharon Belenzon & Andrea Patacconi, 2015. "Killing the Golden Goose? The Decline of Science in Corporate R&D," NBER Working Papers 20902, National Bureau of Economic Research, Inc.
- Zhili Tian & Ralph Siebert, 2020. "Dynamic Effects of Licensing and Knowledge Transfer across Research Stages: Evidence from the Pharmaceutical Industry," CESifo Working Paper Series 8311, CESifo.
- Filson, Darren & Morales, Rosa, 2006. "Equity links and information acquisition in biotechnology alliances," Journal of Economic Behavior & Organization, Elsevier, vol. 59(1), pages 1-28, January.
- Barrenho, E & Smith, PC & Miraldo, M, 2013. "The determinants of attrition in drug development: a duration analysis," Working Papers 12204, Imperial College, London, Imperial College Business School.
More about this item
Keywords
Research Development Biotechnology Pharmaceuticals Externalities;JEL classification:
- C72 - Mathematical and Quantitative Methods - - Game Theory and Bargaining Theory - - - Noncooperative Games
- L13 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Oligopoly and Other Imperfect Markets
- O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-02107357. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.